7:00 - 9:00 p.m. Registration

7:00 - 9:00 a.m.

Registration

8:30 a.m.

Continental Breakfast

9:00 a.m.

Welcome and Introductions

Keynote Address

9:10 a.m.

Top Ten Advances in Vaccinology in the Past Ten Years Stanley A. Plotkin, M.D. Aventis Pasteur University of Pennsylvania

9:45 a.m.

Questions and Answers

Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences

9:50 a.m.

HIV Vaccine Progress Andrew J. McMichael, Ph.D. University of Oxford

10:25 a.m.

Questions and Answers

10:30 a.m.

Coffee Break

Symposium 1: Ethical Aspects of Vaccinology

11:00 a.m.

Lessons from the Rotavirus Vaccine: An Overview of the Issues F. Marc LaForce, M.D. Basic Support for Institutionalizing Child Survival (BASICS II)

11:20 a.m.

Questions and Answers

11:25 a.m.

Lessons from the Rotavirus Vaccine: Ethical Considerations Christine Grady, R.N., Ph.D. National Institutes of Health

11:45 a.m.

Questions and Answers

11:25 a.m.

Ethical Issues in Conducting Clinical Trials in Endemic Areas Gerald T. Keusch, M.D. National Institutes of Health

12:10 p.m.

Questions and Answers

12:15 p.m.

Lunch

Submitted Presentations

1:45 p.m.

Submitted Presentations 1

3:15 p.m.

Coffee Break

Symposium 2: Vaccination, Auto-Immunity and Auto-Immune Diseases

3:45 p.m.

The Significance of Immunological Mimicry for the Development of New Vaccination Strategies Robert S. Fujinami, Ph.D. University of Utah School of Medicine

4:10 p.m.

Questions and Answers

4:15 p.m.

Integrated Approaches to Assess and Limit the Risk of Auto-Immune Adverse Effects Paul-Henri Lambert, M.D. University of Geneva

5:10 p.m.

Questions and Answers

5:15 p.m.

Potential Vaccination Approaches to Prevent or Treat Auto-Immune Diseases David C. Wraith, Ph.D. University of Bristol

5:40 p.m.

Questions and Answers

5:45 p.m.

Adjournment

6:30 p.m.

Opening Reception

7:30 p.m.

Presentation of the Albert B. Sabin Gold Medal

7:00 a.m. - 8:00 a.m.	Registration
7:30 a.m.	Continential Breakfast
Symposium 5: New Approaches to Vaccine Developments
8:00 a.m.	Introduction N. Regina Rabinovich, M.D. Malaria Vaccine Initiative at Program for Appropriate Technology and Health (PATH)
8:05 a.m.	Use of Novel Mass Spectrometry Technology in Vaccine Development Gregory A. Poland, M.D. Mayo Clinic and Foundation
8:25 a.m.	Questions and Answers
8:35 a.m.	Use of Microchip Array and Gene Expression Technology in Vaccine Development Seyed E. Hasnain, Ph.D. Centre for DNA Fingerprinting and Diagnostics (India)
8:55 a.m.	Questions and Answers
9:05 a.m.	Use of Transgenic Animals for Vaccine Development Harry M. Meade, Ph.D. Genzyme Transgenics
9:25 a.m.	Questions and Answers
9:35 a.m.	Progress in the Use of Plants as Vaccine Production or Delivery Systems Carol O. Tacket, M.D. University of Maryland School of Medicine
Poster and Exhibit Session
10:05 a.m.	Poster and Exhibit Session (with Coffee Break)
Submitted Presentations
11:00 a.m.	Submitted Presentations
12:00 p.m.	Lunch
1:30 p.m.	Poster and Exhibit Tear-Down
Symposium 6: Vaccines for Bioterrorist Candidate Agents and Other Dangerous Exotic Diseases
1:30 p.m.	Vaccines for Smallpox and Poxviruses James W. LeDuc, Ph.D. Centers for Disease Control and Prevention
1:50 p.m.	Vaccines for Lassa and Ebola Infections Joseph B. McCormick, M.D. Aventis Pasteur
2:10 p.m.	Progress on Vaccines for Brucellosis Colonel David L. Hoover, M.D. Walter Reed Army Institute of Research
2:30 p.m.	Update on Vaccines Against Anthrax Colonel Arthur M. Friedlander, M.D. U.S. Army Medical Research Institute of Infectious Diseases
2:50 p.m.	Current Research into Vaccines Against Plague Lieutenant Colonel Gerry P. Andrews, Ph.D. U.S. Army Medical Research Institute of Infectious Diseases
3:10 p.m.	Questions and Answers (Panel)
3:30 p.m.	Coffee Break
Symposium 7: Issues in Vaccine Safety
3:50 p.m.	Adventitious Agent Testion Philip R. Krause, M.D. U.S. Food and Drug Administration
4:10 p.m.	Update on Preservatives and Excipients William M. Egan, Ph.D. U.S. Food and Drug Administration
4:30 p.m.	Neurovirulence Testing Kathryn M. Carbone, M.D. U.S. Food and Drug Administration
4:50 p.m.	BSE-Implicated Components in the Preparation of Vaccines: An Update David M. Asher, M.D. U.S. Food and Drug Administration
5:10 p.m.	Questionss and Answers (Panel)
5:25 p.m.	Participant Evaluation
5:30 p.m.	Adjournment

• Back to NFID-SPONSORED CONFERENCES